SCHEMBL13113151

SCHEMBL13113151

CC(=O)CNC(=O)c1ccc(N)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.70
KDM4E B2RXH2 1/20 0.70
HIF1A Q16665 1/20 0.70
SLC22A6 Q4U2R8 1/20 0.70
SLC22A8 Q8TCC7 1/20 0.70
LMNA P02545 4/20 0.58
SLC22A2 O15244 1/20 0.58
SLC22A1 O15245 1/20 0.58
ALDH1A1 P00352 1/20 0.58
TSHR P16473 1/20 0.58
ACHE P22303 1/20 0.58
MAPK1 P28482 1/20 0.58
CYP2C19 P33261 1/20 0.58
BLM P54132 1/20 0.57
PMP22 Q01453 1/20 0.57
EPHX2 P34913 1/20 0.53
POLB P06746 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MEN1 O00255 1/20 0.50
PKM P14618 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13203130 0.90 KDM4E (0.53) MAPTKDM4EHIF1ASLC22A6SLC22A8
SCHEMBL13202996 0.84 RAB9A (0.49) MAPTKDM4EHIF1ASLC22A6SLC22A8
Aminohippuric Acid SCHEMBL196513 0.82 KDM4E (1.00) MAPTKDM4EHIF1ASLC22A6SLC22A8
SCHEMBL11132564 0.82 KDM4E (0.72) MAPTKDM4EHIF1ASLC22A6SLC22A8
SCHEMBL1913984 0.82 KDM4E (0.72) MAPTKDM4EHIF1ASLC22A6SLC22A8
SCHEMBL17299366 0.82 KDM4E (0.67) MAPTKDM4EHIF1ASLC22A6SLC22A8
SCHEMBL5436981 0.82 TDP1 (0.60) MAPTLMNAALDH1A1POLBTDP1
SCHEMBL7320052 0.82 KDM4E (0.71) MAPTKDM4EHIF1ASLC22A6SLC22A8
SCHEMBL8269147 0.81 HDAC6 (0.59) MAPTKDM4EHIF1ASLC22A6SLC22A8
SCHEMBL13113134 0.81 LMNA (0.59) MAPTKDM4EHIF1ASLC22A6SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376706-B2 Protease detection MOLOGIC LIMITED (GB) 2016-06-28 US disclosed
US-20150152471-A1 PROTEASE DETECTION MOLOGIC LIMITED (GB) 2015-06-04 US disclosed
US-8993253-B2 Protease detection MOLOGIC LTD (GB) 2015-03-31 US disclosed
US-20100256355-A1 OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING Research Foundation ITSUU Laboratory and Shionogi & Co., Ltd. 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256355-A1 OXAZOLIDINONE DERIVATIVE HAVING 7-MEMBERED HETERO RING NR0B2, NR0B1, NR2C2 MAPT 4696/4885KDM4E 3762/4885HIF1A 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.